P2RX7 modulators in therapy
US11919854B2 · kind B2 · utility
0Cited by
1References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 29, 2019 |
| Grant date | Mar 5, 2024 |
| Priority date | — |
| Expiry date | May 20, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula (I), their enantiomers and their pharmaceutically acceptable salts, and their use in therapy, particularly for the treatment of cancer or inflammatory diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.